Alicia Teagle

HERMESA is a UK based angel syndicate investing in extraordinary female (co)founded start-ups. We are a community of operators who know what it takes to build successful start-ups and we invest smart money – capital and expertise – to help change the funding landscape for women founders.

Stabiliti is building the infrastructure to embed nature funding into our core economy — making it simple for everyone to fund nature restoration through everyday transactions. We partner with leading businesses to embed small, transparent contributions into products prices, creating a consistent source of funding for verified nature-restoration projects. Our model — Green Margin — enables companies to offer their customers an effortless way to support rewilding, biodiversity, and climate-positive initiatives that are local, visible, and measurable. Each contribution is traceable and auditable, giving brands confidence, customers trust, and nature the resources it urgently needs. By connecting commerce to restoration, we’re closing the nature-funding gap by creating a perpetual funding machine for nature. Nature doesn’t sleep, so why should its funding?

Albert Labs (CSE: ABRT) is a bio-pharmaceutical company pursuing licensing approval for active compounds from natural sources; providing access to effective prescription medicines for people suffering from mental health disorders. Our team of drug development experts leverage advanced culture technology and extraction methods to produce unique and effective natural medicines. We develop clinical solutions through an approved, fast track regulatory pathway focusing on Real World Evidence (RWE). RWE studies are an increasingly recognized clinical access route, heavily used in oncology and recently, in the successful development of COVID-19 vaccines. Through collaborations with research institutions, hospital centres and government agencies, we utilise existing clinical infrastructure to deliver and improve patient access to their treatment. Our first drug target, KRN-101 for a potential solution for cancer-related anxiety, will support an initial market of over 15 million people with an estimated 1 million new sufferers each year.

HERMESA is a UK based angel syndicate investing in extraordinary female (co)founded start-ups. We are a community of operators who know what it takes to build successful start-ups and we invest smart money – capital and expertise – to help change the funding landscape for women founders.

Stabiliti is building the infrastructure to embed nature funding into our core economy — making it simple for everyone to fund nature restoration through everyday transactions. We partner with leading businesses to embed small, transparent contributions into products prices, creating a consistent source of funding for verified nature-restoration projects. Our model — Green Margin — enables companies to offer their customers an effortless way to support rewilding, biodiversity, and climate-positive initiatives that are local, visible, and measurable. Each contribution is traceable and auditable, giving brands confidence, customers trust, and nature the resources it urgently needs. By connecting commerce to restoration, we’re closing the nature-funding gap by creating a perpetual funding machine for nature. Nature doesn’t sleep, so why should its funding?

Neighbourly is an award-winning giving platform that helps businesses make a positive impact in their communities by donating volunteer time, money and surplus products, all in one place. We were founded in 2014 with the aim of helping businesses deliver meaningful and sustainable community investment, into thousands of locations across the UK and Ireland. We believe that by putting local impact at the heart of responsible business we can create a system that works for everyone. We’ve grown into an award-winning, market leading CSR platform that serves some of the worlds biggest companies and supports thousands of local good causes working to improve lives and habitats in our neighbourhoods. In 2015 we became one of the UK’s very first B Corporations, meaning we’re a for-profit company certified by the non-profit B Lab to meet rigorous standards of social responsibility and environmental performance, accountability and transparency. Being a B Corp underpins our core values and belief that business can be a force for good. Together with our fellow B Corps around the world we are redefining how sustainable communities are built and what success in business means. In 2020 we were accredited by the Good Business Charter, launched the Neighbourly Foundation to provide continued financial support to local community causes. The Neighbourly Foundation is now a Marks & Spencer Sparks Charity. Businesses can find out more by getting in touch on: hello@neighbourly.com Charities and community causes can set up a page for free here: www.neighbourly.com/goodcause/new

Albert Labs (CSE: ABRT) is a bio-pharmaceutical company pursuing licensing approval for active compounds from natural sources; providing access to effective prescription medicines for people suffering from mental health disorders. Our team of drug development experts leverage advanced culture technology and extraction methods to produce unique and effective natural medicines. We develop clinical solutions through an approved, fast track regulatory pathway focusing on Real World Evidence (RWE). RWE studies are an increasingly recognized clinical access route, heavily used in oncology and recently, in the successful development of COVID-19 vaccines. Through collaborations with research institutions, hospital centres and government agencies, we utilise existing clinical infrastructure to deliver and improve patient access to their treatment. Our first drug target, KRN-101 for a potential solution for cancer-related anxiety, will support an initial market of over 15 million people with an estimated 1 million new sufferers each year.

Tumelo’s mission is to empower shareholder democracy with technology that supports impactful stewardship. Since our inception in 2018, weve dedicated ourselves to developing state-of-the-art investor-voting technologies. Our pass-through voting technology enables institutional and retail investors in pooled funds to vote their shares, offering greater choice and optionality when it comes to voting stewardship. We believe that this technology has the potential to create a more transparent and representative stewardship process, which will lead to better outcomes for investors and the industry as a whole. To find out more about our voting solutions, head to https://www.tumelo.com/